Abstract Body

Background: The female genital tract (FGT) is a critical mucosal site for HIV transmission, and inflammation in the FGT prior to HIV exposure is thought to facilitate HIV infection. IL-1β has been identified as one of the key pro-inflammatory cytokines associated with HIV acquisition risk in women when detected at high levels in cervicovaginal (CV) lavages. Little is known about the mucosal factors that induce CV IL-1β secretion, but identification of the stimuli and inflammatory pathways could lead to anti-inflammatory interventions that may reduce HIV acquisition risk. We hypothesize that pathogen-associated molecular patterns (PAMPs) lead to activation of the inflammasome in the FGT, resulting in IL-1β secretion. Methodology: To determine whether PAMPs induce inflammasome activation in the female genital tract, primary human immortalized endocervical (End1) and ectocervical (Ect1) epithelial cell lines were treated with TLR 2/6, 3, 4, 7/8, and 9 ligands followed by ATP. Activated caspase-1 was measured with a FAM-YVAD-FMK fluorescent probe and detected by flow cytometry, with exclusion of necrotic cells using propidium iodide. IL-1β secretion was assessed independently by ELISA (R&D) or in conjunction with other human cytokines by Luminex (Millipore). Quantitative PCR was performed using validated primers and normalized to human GAPDH. Humanized BLT mice received repeated intravaginal poly(I:C) treatments, and inflammatory responses were measured in CV lavages by Luminex. Results: The TLR3 and RIG-I agonist poly(I:C) induced a two-fold increase in activated caspase-1 in End1 cells (p<0.05), and ODN2006 induced a threefold increase in End1 and Ect1 cells (p<0.05) relative to no treatment. Poly(I:C) treatment also caused a significant and dose-dependent increase in IL-1β secretion from both End1 and Ect1 cells (p<0.01), while other TLR ligands did not. TLR3, RIG-I, and NLRP3 were expressed at baseline in both End1 and Ect1 cells and upregulated by poly(I:C) treatment. In response to poly(I:C) but not LPS and FSL1, End1 and Ect1 cells strongly upregulated expression of human beta defensin 2 and IFN-β. In vivo, repeated intravaginal treatment of poly(I:C) in humanized mice induced secretion of pro-inflammatory cytokines like human IL-1β and IFN-α2, as well as T cell chemoattractants such as RANTES and MIP-1β. Conclusions: Poly(I:C) induces IL-1β secretion when applied to human cervical epithelial cells in vitro and humanized mice in vivo. The mechanism of IL-1β secretion appears to be inflammasome mediated, as measured by caspase-1 activation, and NLRP3 and RIG-I are potential triggers. Future work will determine which bacteria and viruses are associated with genital IL-1β secretion and the potential role in mediating risk of HIV acquisition in women.